TRBV9 and geroderma osteodysplastica: Beyond functional disparities, we noted that these cell types closely correlate with GO-specific T cell antigenic epitopes, pinpointing unique antigen clones like TRAV1-2 and TRBV9, which could pave the way for novel therapeutic strategies in GO management.